Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lymphoma, Large B-Cell, Diffuse 2Triple Negative Breast Neoplasms 1Small Cell Lung Cancer Extensive Stage 1Pathologic Complete Response 1Oesophagogastric Cancer 1Lymphoma, T-Cell, Peripheral 1Lymphoma, B-Cell, Marginal Zone 1HR+/HER2- Breast Cancer 1Congenital Abnormalities 1Breast Neoplasms 1

Interventions

camrelizumab 1Epirubicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Small Cell Lung Cancer Extensive Stage × Epirubicin × Clear all
NCT03755115 2019-01-16

SHR-1210 Combined With Epirubicin in the Treatment of Extensive Disease Small Cell Lung Cancer

Henan Cancer Hospital

Phase 2 Unknown
40 enrolled
Thoracic

Small Cell Lung Cancer Extensive Stage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡